Antonella Petrillo1, Roberta Fusco2, Mario Petrillo1, Vincenza Granata1, Francesco Bianco3, Massimiliano Di Marzo3, Paolo Delrio3, Fabiana Tatangelo4, Gerardo Botti4, Biagio Pecori5, Antonio Avallone6. 1. Division of Radiology, "Istituto Nazionale Tumori Fondazione Giovanni Pascale, IRCCS", Via Mariano Semmola, 80131, Naples, Italy. 2. Division of Radiology, "Istituto Nazionale Tumori Fondazione Giovanni Pascale, IRCCS", Via Mariano Semmola, 80131, Naples, Italy. r.fusco@istitutotumori.na.it. 3. Division of Colorectal Surgical Oncology, "Istituto Nazionale Tumori Fondazione Giovanni Pascale, IRCCS", Via Mariano Semmola, 80131, Naples, Italy. 4. Division of Diagnostic Pathology, "Istituto Nazionale Tumori Fondazione Giovanni Pascale, IRCCS", Via Mariano Semmola, 80131, Naples, Italy. 5. Division of Radiotherapy, "Istituto Nazionale Tumori Fondazione Giovanni Pascale, IRCCS", Via Mariano Semmola, 80131, Naples, Italy. 6. Division of Abdominal Oncology, "Istituto Nazionale Tumori Fondazione Giovanni Pascale, IRCCS", Via Mariano Semmola, 80131, Naples, Italy.
Abstract
PURPOSE: To investigate the potential of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to discriminate responder from non-responder patients after preoperative chemoradiotherapy (pCRT) in locally advanced rectal cancer (LARC). MATERIALS AND METHODS: One hundred and fifty-eight consecutive patients were enrolled in this prospective study. We compared morphological MRI (mMRI) using T2-weighted images about tumor presence and invasiveness, and functional DCE-MRI using time-intensity curve (TIC) visual inspection (qMRI), classifying TIC shape into three types: type 1, persistent enhancement; type 2, high enhancement with plateau; type 3, high enhancement with wash-out. Clinical TNM was obtained before and after CRT by radiological consensus of two expert radiologists. Pathological tumor-nodes-metastasis classification and tumor regression grade (TRG) were confirmed as the golden standard. Non-parametric test, sensitivity, specificity, and positive and negative predictive values were calculated. RESULTS: Ninety-eight patients (62%) were classified as responders (TRG ≤ 2), while 60 (38%) were classified as non-responders. Sensitivity, specificity, and accuracy were 52, 78, and 62% for mMRI, and 81, 85, and 82% for qMRI, respectively. CONCLUSIONS: TIC visual inspection may be one of the potential biomarkers over morphological analysis using DCE-MRI data to assess pathological response after pCRT in LARC.
PURPOSE: To investigate the potential of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to discriminate responder from non-responder patients after preoperative chemoradiotherapy (pCRT) in locally advanced rectal cancer (LARC). MATERIALS AND METHODS: One hundred and fifty-eight consecutive patients were enrolled in this prospective study. We compared morphological MRI (mMRI) using T2-weighted images about tumor presence and invasiveness, and functional DCE-MRI using time-intensity curve (TIC) visual inspection (qMRI), classifying TIC shape into three types: type 1, persistent enhancement; type 2, high enhancement with plateau; type 3, high enhancement with wash-out. Clinical TNM was obtained before and after CRT by radiological consensus of two expert radiologists. Pathological tumor-nodes-metastasis classification and tumor regression grade (TRG) were confirmed as the golden standard. Non-parametric test, sensitivity, specificity, and positive and negative predictive values were calculated. RESULTS: Ninety-eight patients (62%) were classified as responders (TRG ≤ 2), while 60 (38%) were classified as non-responders. Sensitivity, specificity, and accuracy were 52, 78, and 62% for mMRI, and 81, 85, and 82% for qMRI, respectively. CONCLUSIONS:TIC visual inspection may be one of the potential biomarkers over morphological analysis using DCE-MRI data to assess pathological response after pCRT in LARC.
Authors: C D Pham; T P Roberts; N van Bruggen; O Melnyk; J Mann; N Ferrara; R L Cohen; R C Brasch Journal: Cancer Invest Date: 1998 Impact factor: 2.176
Authors: S Andreola; E Leo; F Belli; G Bonfanti; G Sirizzotti; P Greco; F Valvo; G Tomasic; G F Gallino Journal: Ann Surg Oncol Date: 2001-08 Impact factor: 5.344